Recent Finacing
Recent Raise
Prolynx is a biotechnology company developing ultra-long-acting peptide therapeutics for obesity and related metabolic diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Prolynx.
